Skip to main content
. 2015 Jun 23;113(3):382–389. doi: 10.1038/bjc.2015.223

Figure 3.

Figure 3

Hazard ratio and 95% CIs (censored at 10 years) for prostate cancer death for a one unit change in CCP score for different clinical subgroups and CAPRA risk groups. P-values after each variable indicate significance of a test for heterogeneity.